PeerVoice Endocrinology & Metabolic Disorders Audio
By PeerVoice
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by PeerVoice
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 29
Reviews: 0
Episodes: 61
Description
PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Endocrinology & Metabolic Disorders that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.
| Episode | Date |
|---|---|
|
Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic Health
|
Jun 29, 2026 |
|
Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic Disease
|
Jun 09, 2026 |
|
Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice
|
May 18, 2026 |
|
Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We Can
|
Apr 29, 2026 |
|
Colin M. Dayan, MA, MBBS, FRCP, PhD - Innovation Through Immunomodulation: The Practicalities of Delaying the Progression of Type 1 Diabetes
|
Apr 29, 2026 |
|
Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies
|
Feb 04, 2026 |
|
Ira Goldberg, MD - Mastering the Fundamentals of Care for Chylomicronemia: Following the Patient Care Pathway From Differential Diagnosis to Modern Management
|
Jan 14, 2026 |
|
Ira Goldberg, MD - The Expanding Treatment Landscape for Familial Chylomicronemia Syndrome: Exploring New Options and Opportunities
|
Dec 31, 2025 |
|
John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient Outcomes
|
Dec 23, 2025 |
|
Stuart C. Gordon, MD - Data-Driven Decision-Making in Primary Biliary Cholangitis: Evaluating the Expanding Evidence Base for PPAR Agonists
|
Nov 19, 2025 |
|
David Jones, OBE, MD, PhD - New Options and Opportunities for Personalised Treatment of Primary Biliary Cholangitis: Have You Updated Your Approach?
|
Nov 08, 2025 |
|
Eva Diehl - Wiesenecker, MD - Rare Causes of Abdominal Pain: Differential Diagnosis of Uncommon but Diagnosable Causes in the Emergency Room
|
Sep 11, 2025 |
|
Christie M. Ballantyne, MD - At the Forefront of the Latest Developments in FCS: Expert Perspectives on Emerging Evidence
|
Aug 27, 2025 |
|
Martin Metz, MD - Bringing Chronic Spontaneous Urticaria Under Control: Available and Anticipated Strategies for Escalating Treatment
|
Aug 20, 2025 |
|
Angela Kay Fitch, MD, FACP, MFOMA - Separating Signal From Noise: Overcoming the Challenges of Obesity Management in Real-World Clinical Practice
|
Aug 04, 2025 |
|
Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis
|
Jun 23, 2025 |
|
Richard David Graham Leslie, MD, FRCP, FAoP - When Could Dysglycaemia in Adults Be Type 1 Diabetes? Expert Perspectives on Recognising and Addressing Diagnostic Complexities and Challenges
|
May 30, 2025 |
|
Francesco Lapi, PharmD, PhD - Chronic, Painful, and Often Overlooked: Working Together to Optimise Outcomes in Hidradenitis Suppurativa
|
Apr 08, 2025 |
|
Kris V. Kowdley, MD - Advancing Individualized Treatment Strategies in Patients With Primary Biliary Cholangitis
|
Feb 17, 2025 |
|
Kevin Fernando, MBChB, BSC Hons (Med Sci), MSc Diabetes - The Many Faces of PBC: Recognising Opportunities to Optimise Identification and Intervention Across Diverse Patient Populations
|
Dec 30, 2024 |
|
Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care
|
Dec 27, 2024 |
|
Olga Kordonouri, MD - Confronting the Silent Progression of Type 1 Diabetes: Rationales and Roadmaps for Early Detection and Proactive Intervention
|
Dec 19, 2024 |
|
Gideon Hirschfield, MB BChir, FRCP, PhD - Keeping Pace With the Latest in PBC: Practical Perspectives on What’s New and What’s Next
|
Dec 19, 2024 |
|
Ian SD Roberts, MBChB, FRCPath / Joris Roelofs, MD, PhD - Best Practices in Renal Pathology: Avoiding Common Pitfalls in the Diagnostic Pathways for Glomerular Diseases
|
Dec 17, 2024 |
|
Kris V. Kowdley, MD - Navigating Cases of PBC Alongside the Experts: Best Practices in Tracking Treatment Response and Targeting Contemporary Goals of Care
|
Dec 13, 2024 |
|
Jonathan Barratt, PhD, FRCP / Joris Roelofs, MD, PhD - The Central Role of Renal Pathology in the Differential Diagnosis of Glomerular Diseases: Sharing Expertise, Experience, and Essential Next Steps
|
Nov 15, 2024 |
|
Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey
|
Oct 25, 2024 |
|
Angela Fitch, MD, FACP, MFOMA - This Cannot Weight: A Specialist Guide to Weight Management and Obesity Associated With Emotional Eating Behaviours
|
Oct 25, 2024 |
|
Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) - Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?
|
May 21, 2024 |
|
Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
|
Mar 28, 2024 |
|
George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action
|
Feb 28, 2024 |
|
Carel le Roux, MD, PhD - Prioritising Obesity Care in Our Clinical Practices: Why We Must and How We Can
|
Jan 22, 2024 |
|
Meena B. Bansal, MD, FAASLD - The Many Faces of MASH: Recognising Risk, Improving Identification, and Maximising Management in the Primary Care Setting
|
Jan 03, 2024 |
|
Andreea Ciudin, MD, PhD - Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on the Modernisation of Obesity Care
|
Dec 21, 2023 |
|
Lise Lotte Gluud, MD - Following the Evidence-Based Road: Improving Care for MASH Through Use of Clinical Care Pathways in Primary Care
|
Nov 28, 2023 |
|
Paolo Sbraccia, MD, PhD - Providing State of the Art Care for People With Obesity: Can We Break Free From the Status Quo?
|
Oct 30, 2023 |
|
Tina Vilsbøll, MD, DMSc - Overcoming Barriers to Basal Insulin in T2DM: Appreciating the Preferences and Perspectives of Patients With T2DM
|
Oct 30, 2023 |
|
Harpreet Bajaj, MD, MPH - Innovating Our Approach to the Initiation of Insulin in T2DM: The Why and the How
|
Sep 29, 2023 |
|
Melanie J. Davies, CBE, FRCP, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies
|
Aug 23, 2023 |
|
Sarah Jarvis, MBE, FRCGP - Achieving Shared Goals Across the Spectrum of CKD and HF
|
Aug 22, 2023 |
|
Mansoor Husain, MD - Integrating GLP-1 RAs Into Our Cardiology Care Pathways: Who, When, and Why?
|
Aug 22, 2023 |
|
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
|
Jul 26, 2023 |
|
Sarah Jarvis, MBE, FRCGP - Identifying Intervention Points in CKD and HF From Multidisciplinary Viewpoints
|
Jun 19, 2023 |
|
Verónica Vázquez Velázquez, PhD - Optimising Obesity Care in Adolescent Patients: Practical Blueprints to Overcome Barriers
|
May 12, 2023 |
|
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs
|
May 05, 2023 |
|
Luis Alberto Moreno, MD, PhD / Aaron Kelly, PhD - Assessing and Alleviating the Weight of Obesity in Adolescent Patients
|
Apr 19, 2023 |
|
Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians
|
Apr 11, 2023 |
|
Angela Fitch, MD, FACP, Dipl. ABOM - Give the Heart a Break: Improving Cardiovascular Risk and Outcomes With Modern Weight Management Strategies
|
Mar 30, 2023 |
|
Jens Lundgren, MD - Applying Current European Guidance on Treating COVID-19 in Hospitalized Patients
|
Mar 23, 2023 |
|
Samuel Seidu, MD, FRCGP, FRCP (Edin) - The Power of the Primary Point of Contact: Taking Obesity From Obstacle to Opportunity
|
Mar 23, 2023 |
|
Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient Outcomes
|
Mar 23, 2023 |
|
Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter?
|
Feb 03, 2023 |
|
Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More
|
Feb 03, 2023 |
|
Tali Cukierman-Yaffe, MD, MSc - Beyond Metabolic Benefits: Recognising and Reducing the Risk of Stroke in Type 2 Diabetes With GLP-1 RAs
|
Dec 16, 2022 |
|
Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes
|
Dec 05, 2022 |
|
Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs
|
Dec 05, 2022 |
|
Melanie J. Davies, CBE, FRCP, FMedSci - Clinical Challenges in Insulin Initiation: Overcoming Obstacles to Improved Glycaemic Control in Type 2 Diabetes
|
Dec 05, 2022 |
|
Aoife Egan, MB, BCh, PhD - Insulin Resistance and Women’s Health: Case Studies in Gestational Diabetes and Polycystic Ovarian Syndrome
|
Nov 11, 2022 |
|
"Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians
"
|
Nov 07, 2022 |
|
Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?
|
Sep 20, 2022 |
|
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
|
May 24, 2022 |